ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.774,71
0,43%
S&P 500
5.304,72
0,70%
Dow Jones
39.069,59
0,01%
Euro vs US Dollar
1,08785
0,16%
Bitcoin
67.752,39
-2,35%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. MiroMatrix Medical Inc (MIRO)

  7. MiroMatrix Medical Inc (MIRO) News

MIRO

MiroMatrix Medical (MIRO)

MiroMatrix Medical Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:MIRO
DatumZeitQuelleÜberschriftSymbolFirma
26/12/202312h02Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:MIROMiroMatrix Medical Inc
18/12/202322h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MIROMiroMatrix Medical Inc
18/12/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MIROMiroMatrix Medical Inc
13/12/202322h51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MIROMiroMatrix Medical Inc
13/12/202322h50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MIROMiroMatrix Medical Inc
13/12/202322h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MIROMiroMatrix Medical Inc
13/12/202322h46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MIROMiroMatrix Medical Inc
13/12/202322h44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MIROMiroMatrix Medical Inc
13/12/202316h14Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:MIROMiroMatrix Medical Inc
13/12/202316h13Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:MIROMiroMatrix Medical Inc
13/12/202316h12Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:MIROMiroMatrix Medical Inc
13/12/202316h03Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:MIROMiroMatrix Medical Inc
13/12/202315h15Business WireUnited Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and MergerNASDAQ:MIROMiroMatrix Medical Inc
12/12/202317h22Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:MIROMiroMatrix Medical Inc
12/12/202312h00Business WireUnited Therapeutics and Miromatrix Medical Announce Successful Tender OfferNASDAQ:MIROMiroMatrix Medical Inc
07/12/202322h47Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MIROMiroMatrix Medical Inc
30/11/202323h14Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:MIROMiroMatrix Medical Inc
14/11/202322h05GlobeNewswire Inc.Miromatrix Reports Third Quarter 2023 ResultsNASDAQ:MIROMiroMatrix Medical Inc
14/11/202322h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MIROMiroMatrix Medical Inc
13/11/202313h01Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:MIROMiroMatrix Medical Inc
30/10/202312h03Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:MIROMiroMatrix Medical Inc
30/10/202311h12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MIROMiroMatrix Medical Inc
30/10/202311h05GlobeNewswire Inc.United Therapeutics to Acquire Miromatrix MedicalNASDAQ:MIROMiroMatrix Medical Inc
30/10/202311h00Business WireUnited Therapeutics to Acquire Miromatrix MedicalNASDAQ:MIROMiroMatrix Medical Inc
11/10/202322h05GlobeNewswire Inc.Miromatrix to Present at the 2023 ISODP Organ Donation CongressNASDAQ:MIROMiroMatrix Medical Inc
05/10/202322h30GlobeNewswire Inc.Miromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the MesaNASDAQ:MIROMiroMatrix Medical Inc
06/09/202322h01GlobeNewswire Inc.Miromatrix Announces Participation in H.C. Wainwright Global Investment ConferenceNASDAQ:MIROMiroMatrix Medical Inc
05/09/202322h04GlobeNewswire Inc.Miromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics WorkshopNASDAQ:MIROMiroMatrix Medical Inc
14/08/202322h02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MIROMiroMatrix Medical Inc
14/08/202322h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MIROMiroMatrix Medical Inc
 Showing the most relevant articles for your search:NASDAQ:MIRO

Kürzlich von Ihnen besucht

BIT
F17455
Vontobel Financial Produ...
USOTC
MNKTQ
Mallinckrodt (PK)
NASDAQ
CPSH
CPS Technologies
COIN
FDCDUST
FLYINGDEER
USOTC
MEGDF
Megado Gold (PK)
NASDAQ
PSAGW
Property Solutions Acqui...
EU
DBRAK
Departement Bouches du R...
USOTC
LIQDQ
Liquid (CE)
GATE
POOLZETH
$Poolz Finance
USOTC
YMTKF
Yamato Kogyo (PK)
USOTC
GTSWF
GetSwift Technologies (CE)
USOTC
GWAV
USOTC
MAUGF
Magnetic Resources NL (PK)
BIT
F13605
Vontobel Financial Produ...
EU
FRSG00014R43
SG Issuer Sg Issuer Mc M...
USOTC
CWHHF
Carry Wealth (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten